Gilenya (fingolimod): Updated recommendations to minimise the risk of drug-induced liver injury (DILI)
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
|Therapeutic area (MeSH)||
Periodic safety update report
|Human ATC code||